All Comments by Elliott Mufson

  1. Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease.
  2. Weight, blood pressure, osmolarity, and glucose levels across various stages of Alzheimer's disease and vascular dementia.
  3. Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease.
  4. A computational model of the progression of Alzheimer's disease.
  5. Aluminum concentrations in drinking water and risk of Alzheimer's disease.
  6. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.
  7. Psychiatric correlates of MR deep white matter lesions in probable Alzheimer's disease.
  8. Apolipoprotein E and Alzheimer's disease: a review of recent studies.
  9. Down syndrome.
  10. Educational level and neuropsychological heterogeneity in dementia of the Alzheimer type.
  11. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes.
  12. Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study.
  13. Automated identification and quantitative morphometry of the senile plaques of Alzheimer's disease.
  14. Risk of Alzheimer's disease among elderly patients with anemia: population-based investigations in Olmsted County, Minnesota.
  15. Cognitive enhancement therapy for Alzheimer's disease. The way forward.